Cross-Sector entity
All 1 tracked stories fall under one category: regulation. Of the tracked stories, 1 of 1 also mention 60 Minutes, the most common co-covered peer. We currently track 1 Cross-Sector story that mention SynchroMed II, all published on July 20, 2026.
1 verified story tracked
Last mentioned: Jul 20, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: regulation. Of the tracked stories, 1 of 1 also mention 60 Minutes, the most common co-covered peer. We currently track 1 Cross-Sector story that mention SynchroMed II, all published on July 20, 2026. Each carries 3 original sources on average.
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering SynchroMed II. Shared-story counts are live from our verified record — not editorial picks.
Joint investigation published
SMH, The Age, Brisbane Times, and 60 Minutes release findings from analysis of 81,000 TGA adverse event logs, uncovering systemic database gaps and rising injury trends.
Vicki Kelly receives SynchroMed II implant
The implant leads to a blood clot blocking a spinal cord artery, causing permanent paralysis from the waist down.
An Australian investigation uncovers tens of thousands of unanalysed adverse event reports and database anomalies in the TGA’s device oversight. For legal professionals, the findings represent a goldmine for failure-to-warn claims and regulatory class actions against Medtronic.
Source: smh.com.au · brisbanetimes.com.au
